Difference in gene mutation profile in patients with refractory/relapsed versus newly diagnosed acute myeloid leukemia based on targeted next-generation sequencing-Reference-Cited by-同舟云学术

Difference in gene mutation profile in patients with refractory/relapsed versus newly diagnosed acute myeloid leukemia based on targeted next-generation sequencing

Published:2021-04-29 Issue: Volume: Page:1-12
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Wang Mengzhen¹^ORCID,Wang Ruiqi²,Wang Hong²,Chen Chongjian³,Qin Jiayue³^ORCID,Gao Xiaoning¹,Yu Li¹⁴^ORCID

Affiliation:

1. Department of Hematology, Chinese PLA General Hospital, Beijing, China

2. School of Medicine, Nankai University, Tianjin, China

3. Annoroad Gene Technology Co, Beijing Economic-Technological Development Area, Beijing, China

4. Department of Hematology and Oncology, International Cancer Center, Shenzhen Key Laboratory, Shenzhen University General Hospital, Shenzhen University Clinical Medical Academy, Shenzhen University Health Science Center, Shenzhen, China

Funder

Major New Drug Development Project from Ministry of Science and Technology of China

State Key Program of National Natural Science of China

National Natural Science Foundation of China

Error! Hyperlink reference not valid.

Natural Science Foundation of Shenzhen University General Hospital

Shenzhen Science and Technology investigation project

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link